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A number of studies investigating the biological effects of transcranial direct current
stimulation (tDCS) using magnetic resonance spectroscopy (MRS) have found that
it may affect local levels of γ-aminobutyric acid (GABA), glutamate and glutamine
(commonly measured together as “Glx” in spectroscopy), and N-acetyl aspartate (NAA),
however, these effects depend largely on the stimulation parameters used and the
cortical area targeted. Given that different cortical areas may respond to stimulation in
different ways, the purpose of this experiment was to assess the as yet unexplored
biological effects of tDCS in the posterior superior temporal gyrus (pSTG), an area
that has attracted some attention as a potential target for the treatment of auditory
verbal hallucinations in schizophrenia patients. Biochemical changes were monitored
using continuous, online MRS at a field strength of 3 Tesla. Performing intrascanner
stimulation, with continuous spectroscopy before, during and after stimulation, permitted
the assessment of acute effects of tDCS that would otherwise be lost when simply
comparing pre- and post-stimulation differences. Twenty healthy participants underwent
a repeated-measures experiment in which they received both active anodal and
sham intrascanner stimulation in a stratified, randomized, double-blind experiment. No
significant changes in GABA, Glx, or NAA levels were observed as a result of anodal
stimulation, or between active and sham stimulation, suggesting that a single session
of anodal tDCS to the pSTG may be less effective than in other cortical areas that have
been similarly investigated.
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INTRODUCTION
Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique that
uses constant, low level (0.5–2.0mA) direct current to modulate cortical excitability in a polarity
dependent manner (1). Nitsche and Paulus (2) used the magnitude of motor-evoked potentials
(MEP) as generated by transcranial magnetic stimulation (TMS) as an indication of changes in
excitability and found that tDCS was able to induce changes in excitability of up to 40%, with
anodal stimulation having an excitatory effect, and cathodal stimulation having an inhibitory
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effect. Subsequent studies showed that effects may outlast
the duration of stimulation, with short applications inducing
excitability shifts during stimulation, and ∼10min or more of
stimulation producing persistant effects lasting up to 90min after
current flow has ceased (3) suggesting that tDCS has the ability
to induce long term potentiation (LTP)-like effects on synaptic
plasticity (4).
Due to its purported effects on excitability and synaptic
plasticity, tDCS has been investigated as a potential treatment
for a range of neurological and psychiatric disorders such as
Parkinson’s disease (5), depression (6), and for the treatment
of auditory verbal hallucinations in schziophrenia. A case
reported by Homan et al. (7) found that cathodal tDCS halfway
between T3 and P3 in the 10–20 electroencephelography (EEG)
system was successful in alleviating both hallucinations (−60%
Hallucination Change Scale (HCS) score) and global symptoms
(−20% Postive and Negative Syndrome Scale (PANSS) score).
A randomized control trial conducted by Brunelin et al. (8)
using a similar stimulation paradigm at 2.0mA also showed
improvement in hallucinations (−31% Auditory Hallucination
Rating Scale (AHRS) score) and global symptoms (−13%
PANSS score). Subsequent studies, using similar stimulation
parameters have found both reductions (9) and no significant
differences (10, 11) in symptoms. While tDCS shows great
promise as a potential treatment for schizophrenia, the
lack of consistent findings between these studies highlight
the need for a deeper understanding of the effects of
tDCS.
Although generally accepted that anodal stimulation
typically facilitates excitability and cathodal stimulation inhibits
excitability (12), studies have shown that the effects of tDCS on
excitability are not so simplistic, and depend on a number of
factors such as electrode size and placement, stimulation intensity
and duration, as well as the orientation of neurons relative to
the stimulating electrodes (12–14). Furthermore, Batsikadze
et al. (15) found that while 20min of cathodal stimulation at
1.0mA had an inhibitory effect, 20min of cathodal stimulation
at 2.0mA had an excitatory effect, increasing the magnitude
of measured MEPs. Esmaeilpour et al. (16) showed that the
dose-response relationship in tDCS is not necessarily linear,
and that although increasing current produces a corresponding
increase in brain electric field, it may not necessarily enhance a
neurophysiological, behavioral or clinical outcome. As Woods
et al. (14) caution, it cannot be taken for granted that what
is effective in a particular cortical area is transferable and
applicable to others, rather recommending a “titration” of
parameters.
Abbreviations: BOLD, Blood Oxygen Level Dependent; EEG,
Electroencephalography; ERETIC, Electronic reference to access in vivo
concentrations; FWHM, Full width at half maximum; GABA, Gamma-
aminobutyric acid; Glx, Glutamate and glutamine; GSH, Glutathione; LTP,
Long-term potentiation; MEGA-PRESS, Mescher-Garwood point resolved
spectroscopy; MEP, Motor evoked potential; MRS, Magnetic Resonance
Spectroscopy; NAA, N-acetylaspartate; NAAG, N-acetylaspartylglutamate;
pSTG, Posterior superior temporal gyrus; tDCS, Transcranial direct current
stimulation; TE, Echo time; TMS, Transcranial Magnetic Stimulation; TR,
Repetition time
Despite the observed effectiveness of tDCS, the exact
mechanisms by which it works are not yet fully understood.
Horvath et al. (17) show that changes in cognitive effects alone
may be an unreliable measure of effectiveness. Computational
forward models and simulations have been useful in imaging
current flow, aiding in the design of stimulation paradigms (18)
but do not provide information about neuronal responses to
delivered current or whether the effect is excitatory or inhibitory
in nature.
Krause et al. (19) suggest that tDCS may modulate the
excitation/inhibition balance, that is, the relative contributions of
excitatory and inhibitory inputs to a neural circuit corresponding
to a neuronal event. Using in vivo magnetic resonance
spectroscopy (MRS), the excitation-inhibition balance may
be characterized in terms of the local concentrations of
the excitatory neurotransmitter glutamate and inhibitory
neurotransmitter gamma-aminobutyric acid (GABA). Studies
that have used MRS to investigate the effect of tDCS have found
anodal tDCS to reduce local cortical GABA concentration in the
motor cortex (20, 21) and to increase local concentrations of
glutamate and glutamine, measured together as “Glx,” and N-
acetyl aspartate (NAA) in the intraparietal and prefrontal cortices
(22, 23), the observed reduction in inhibitory neurotransmitter
levels and concurrent increases in excitatory neurotransmitter
levels being consistent with the facilitatory nature of anodal
stimulation. Thus, in vivo MRS provides a window into the
biochemical events underlying tDCS that may also be used
as a biomarker indicating the effectiveness and nature of a
stimulation paradigm.
In this study, MRS was used to investigate the acute
biochemical effects of tDCS in validating its potential for
use as a treatment for auditory-verbal hallucinations in
schizophrenia. However, rather than simply comparing pre-
and post-stimulation spectral acquisitions, biochemical changes
were measured continuously using online MRS in a manner
similar to those used by Bachtiar et al. (24) and Hone-Blanchet
et al. (23). By acquiring spectra continuously over the course
of stimulation, spectral frames could be combined in such
a way that metabolite levels could be measured and tracked
before, during and post stimulation, allowing better insight
into the acute effects of stimulation as opposed to the lasting
effects. Findings in other cortical areas suggest that if anodal
tDCS were to have a similar effect on the local excitation-
inhibition balance, it may bemeasured as a statistically significant
increase in Glx and NAA levels (22, 25) and decrease in
GABA levels (20, 21, 24) and that these changes would be
significantly different under active stimulation when compared to
sham.
MATERIALS AND METHODS
This study was carried out in accordance with the
recommendations and ethical approval of the regional committee
for medical and health research ethics (REK-Vest) REK case
number 2013/2342. All subjects gave written informed consent
in accordance with the Declaration of Helsinki and the
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guidelines drawn up by The Norwegian National Research Ethics
Committee for medical and health research (NEM).
Participants
Twenty healthy participants (mean age: 25 years, range: 19–32;
10 male) participated in the study. All participants were required
to complete a Norwegian language version of the Edinburgh
handedness inventory (26) to determine right-handedness in
an attempt to control for issues related to lateralization of
cortical areas, such that stimulation in the left hemisphere affects
approximately the same functional area in each participant. The
test assessed dominance of right and left hand in performing
10 everyday activities to produce a score ranging between −100
(exclusively left handed) and +100 (exclusively right handed),
participants with a score greater than +40 were considered
to be right handed and were permitted into the study (mean
score: +80, SD: 24). Based on self-report, participants were free
from psychiatric and neurologic conditions and had not used
any psychoactive/psychotropic substances, including no smoking
or other tobacco based or nicotine containing products, for 6
months prior to participating in the experiment. Participants
were also instructed not to consume alcohol for at least 24 h prior
to participation.
Data from one female participant was omitted from final
analyses due to abnormally high measurements of Glx more
than three standard deviations above the group mean (Glx levels
almost 5 times higher than average values), suggesting an error in
spectral acquisition.
tDCS Stimulation
Stimulation was performed using an MR-compatible DC-
Stimulator MR (neuroConn GmbH, Ilmenau, Germany) fitted
with two 5 × 7 cm (35 cm2) MR compatible rubber electrodes.
Given that the motivation for this study was the potential for
tDCS to be used as a treatment for schizophrenia, stimulation
parameters were chosen to emulate those used in previous
studies. Intensity was set at 2.0mA (27) and although the
majority of studies using tDCS as a treatment for auditory-verbal
hallucinations have stimulated for 20min, the prohibitively long
scan time this would necessitate in order to have three equally
long spectroscopy windows meant that stimulation had to be
limited to 10min. The anodal electrode was placed with the
center of the pad on an area over the pSTG, such that the
lower corners of the 7 cm edge of the electrode touch points
T3 and T5 in the EEG 10-20 system. The cathodal electrode
was placed over the contralateral orbitofrontal cortex, a site
commonly used in tDCSmontages for placement of the reference
electrode (2, 12) such that the center of the electrode covered
point AF8 in the EEG 10–20 system. Each electrode was coated
with a layer of Ten20 conductive paste (Weaver and Company,
Aurora, United States of America) at the interface between
electrode and skin to improve both adhesion and conductivity.
Once the electrodes were in place, participants were placed
in the scanner with electrodes attached but not connected to
the stimulation box. Electrodes were only connected prior to
spectroscopy sequences.
This study followed a stratified, randomized, double-blind
design, with both participants and experimenters blind to the
stimulation condition. Each subject participated in two MR-
scanning sessions with tDCS: one with active and one with sham
stimulation, separated by a wash-out period of 1 h outside of the
scanner (12, 28) counterbalanced for order. Double-blinding was
performed by having the stimulation condition determined by a
code, independently predetermined by a researcher not present
at the stimulation, such that each participant underwent both
active and sham stimulation conditions and that equal numbers
experienced active and sham stimulation as the first condition.
MR-Imaging and Spectroscopy
All imaging and spectroscopy was performed on a 3 T GE
750 Discovery Scanner from GE Healthcare (General Electric,
Milwaukee, United States of America) using a standard 8-
channel head coil from Invivo (Invivo corp., Gainsville, Florida,
United States of America).
Following a 3-plane localizer sequence (2D Spin Echo,
TE = 80ms, FOV = 240mm, slice thickness = 8mm, slice
spacing= 15mm) structural anatomical imaging was performed
using a 3D T1 weighted fast spoiled gradient sequence (FSPGR)
(number of slices= 192, slice thickness= 1.0mm, repetition time
(TR) = 7.8ms, echo time (TE) = 2.95ms, field of view = 260
× 260 mm2, flip angle = 14 degrees, matrix = 256 × 256).
These structural images were used to position a 24 × 24 × 24
mm3 voxel for the spectroscopy component of this experiment
in the left pSTG, centered around the primary auditory cortex,
aligned orthogonally in the axial scan plane with no angulation
(Figure 1).
Since the aim of this study was to characterize acute
biochemical changes in terms of the excitation-inhibition
balance, a GABA specific MEGA-PRESS sequence (29) was used
as it provides accurate and stable measurements of GABA, as
well as a measurement of glutamate and glutamine combined
as “Glx” (30). Spectroscopy was performed using a MEGA-
PRESS sequence (TE = 68ms, TR = 1,500ms, 8-way phase
cycling, editing at 1.9 and 7.5 ppm in alternating frames) of
628 paired repetitions, followed by 16 unsuppressed reference
acquisitions for a total scan time of 31min and 48 s. Once 10min
of spectroscopy had elapsed, stimulation was initiated at the
control box located outside the scanner at the control room.
Active stimulation was delivered for 10min with 24 s of ramping
time both before and after the stimulation/sham period at a
constant intensity of 2.0mA. For the sham stimulation condition,
intensity was ramped up to 2.0mA over 24 s, then delivered
for another 40 s, before being ramped down to zero, giving
participants a similar sensation to that they would experience
during active stimulation. Spectroscopy acquisition continued
for 10min in order to assess post-stimulation effects (Figure 2).
Spectral Analysis
While no spectral artifacts were observed during steady-state
tDCS stimulation, mild artifacts were seen in spectral frames
acquired during the ramping periods for both active and sham
stimulation. Frames from these periods were omitted from all
subsequent analyses.
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FIGURE 1 | Voxel placement in the pSTG in one participant: Sagittal (left), axial (middle), and coronal (right) views overlayed on an anatomical scan.
FIGURE 2 | tDCS and MRS: Each participant received both active and sham stimulation, separated by a washout period of 1 h, counterbalanced for order. 24 s of
ramping up and down were incorporated into both active and sham stimulation. MRS was acquired constantly throughout each session. The pre-, during, and
post-stimulation spectroscopy windows did not include frames acquired during ramping.
Following phase adjustment, coil combination, and
realignment, each continuous acquisition was first subdivided
into three smaller blocks of ∼10min, with exact length
depending on how many frames were excluded due to ramping
artifacts, comprising a pre-, during-, and post stimulation block
for each session, hereafter referred to as a three point analysis.
Frames within each block were then averaged together and
within each block, ON, and OFF spectrum pairs were subtracted
to produce a difference spectrum then subjected to quantitative
analysis with LCModel (version 6.3-1J) (31, 32) using a simulated
basis set (33) with Kaiser coupling constants (34) to provide an
estimate of average levels of GABA, glutamate and glutamine
measured together as Glx, glutathione (GSH), NAA, and N-
acetyl aspartate glutamate (NAAG). Metabolite levels were scaled
relative to the unsuppressed water signal acquired at the end of
each spectroscopy sequence.
One issue that affects MEGA-edited GABA spectroscopy
is co-editing of macromolecule (MM) resonances at 1.7 ppm
contaminating the GABA signal in the difference spectrum.
GABA, in this report, refers to both GABA and the co-edited
macromolecule, typically denoted GABA+ (35).
To further investigate acute effects of tDCS, and eliminate
the possibility short-lived metabolic fluctuations being obscured
through averaging, a second analysis was performed in which the
during- and post-stimulation blocks were further subdivided into
two smaller windows in an attempt to uncover any changes in
metabolite concentration during this period, thus providing five
time points over the acquisition, hereafter referred to as the five
point analysis: one 10min pre-stimulation window, two 5min
during-, and two 5min post-stimulation windows.
MRS signals have been demonstrated to be susceptible to line-
broadening artifacts associated with local blood-oxygen-level
dependent (BOLD) effects (36). As an indication of potential
BOLD interference, the full width at half maximum (FWHM)
values as determined by LCModel were used as a measure
of quality control, to ensure the MRS signal had not been
significantly affected between time points.
Statistical Analysis
Statistical analyses were performed using R (37) and the nlme
package (38) to perform a linear mixed effects model analysis
of the effect of tDCS on the concentrations of three metabolites
of interest, namely NAA, Glx, and GABA, over time. This
model specified two groups of participants (active-first and
sham-first) and time period as fixed effects as well as an
interaction effect between the two, with the subject as a random
effect. This model was also used to investigate crossover effects
between the active and sham stimulation conditions due to
the within-subject design of the study, to determine whether
order of stimulation, active first or sham first, may have had
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FIGURE 3 | MEGA-PRESS spectra from one participant showing spectra acquired during the pre-stimulation window (top, blue) during stimulation (middle, red) and
post-stimulation (bottom, green).
any significant effect on results and whether the stimulation
condition in the first session had any lasting effect on the second.
The same model was used for both the 3-point and 5-point
analyses.
RESULTS
Sample spectra from the three-point analysis of an individual
participant are shown in Figure 3 along with spectral quality
metrics for all participants in Table 1. A linear mixed effects
model of the average metabolite concentration across three
time windows (pre-, during-, and post-stimulation) revealed
no significant fluctuations in any of the metabolites of interest
between any time points (Figure 4 and Appendix A). Similarly,
no significant fluctuations in any of the metabolites of interest
were found between any time points in the five-time point
analysis (Figure 4 and Appendix B).
No significant crossover effects were found (Figure 4,
Appendices A, B) indicating both that the order in which
participants received the two different stimulation conditions had
no significant effect on results and that there were no crossover
effects from the first session significantly affecting the second.
There was no significant difference in the change between groups
over time, indicating no difference in fluctuations for any of the
metabolite levels between active and sham conditions.
The FWHM as reported by LCModel was used as an
indication of potential BOLD interference (Tables 2, 3), but
saw very little fluctuation between time points, making BOLD
interference an unlikely source of error.
DISCUSSION
Themontage and stimulation parameters used in this experiment
did not induce a statistically significant effect on Glx, GABA, or
NAA levels as measured with the MRS sequence used, and there
was no significant difference in response observed between the
active and sham stimulation conditions.
The active hypothesis for this experiment was informed by
previous studies in which active anodal stimulation was found to
be associated with increases in Glx and NAA levels (22, 23) and
decreases in GABA levels (20, 21, 24) as measured by MRS. In
comparing these studies with the findings presented here, there
are three key elements to be considered, namely the stimulation
parameters, the MRS acquisition parameters and the site of
stimulation and spectroscopy.
As stated in section tDCS Stimulation, due to
limitations of the experimental design, stimulation
could only be delivered for 10min as opposed
to the 20min previously used in the treatment of schizophrenia
symptoms. Although as little as 7min of stimulation has been
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shown to induce lasting effects after stimulation has ceased (39),
it cannot be taken for granted that the 10min delivered in this
session was sufficient to induce a change. While the stimulation
window was shorter than the 30min used by both Clark et al.
TABLE 1 | Spectral Quality: FWHM, SNR, and mean %CRLB for GABA and Glx
for each stimulation window.
Window FWHM (Hz) SNR Mean GABA Mean Glx
%CRLB %CRLB
Pre Stim 8.22 ± 2.34 20.47 ± 4.71 5.12 4.54
During Stim 8.39 ± 2.41 20.83 ± 4.20 5.16 4.41
Post Stim 8.03 ± 2.18 21.67 ± 4.04 4.91 4.24
(22) and Hone-Blanchet et al. (23) and the 20min and 15min
used by Bachtiar et al. (24) and Kim et al. (20), respectively,
Stagg et al. (21) were able to detect significant changes in GABA
and Glx levels in the left sensorimotor cortex using a similar
TABLE 2 | Average FWHM and standard deviation (sd) as estimated by LCModel
for the 3-point analysis.
Mean FWHM−3-point analysis (Hz)
Pre sd During sd Post sd
Active 7.95 1.86 7.98 1.79 7.59 1.38
Sham 8.46 2.24 8.64 2.24 8.32 2.30
FIGURE 4 | Linear mixed effects model of GABA (upper row), Glx (middle row) and NAA (lower row) levels in the pSTG for both the first and second sessions using
both 3-point (left) and 5-point (right) analyses. p-values shown above each plot indicate significance of interaction effects at each time point relative to baseline.
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TABLE 3 | Average FWHM and standard deviation (sd) as estimated by LCModel for the 5-point analysis.
Mean FWHM−5-point analysis (Hz)
Pre sd During1 sd During2 sd Post1 Sd Post2 sd
Active 7.95 1.86 8.00 1.77 7.94 1.69 7.74 1.73 7.77 1.55
Sham 8.46 2.24 8.50 0.02 8.46 2.06 8.28 2.42 8.46 1.96
MEGA-PRESS sequence at 3 T given only 10min of anodal
stimulation at 1.0mA. The findings of Batsikadze et al. (15) and
Esmaeilpour et al. (16) suggest it is possible that stimulating
at 2.0mA had a different effect to the one predicted. However,
studies conducted by Brunelin et al. (8) and Mondino et al.
(9) both found significant reductions in symptoms of auditory-
verbal hallucinations using stimulation in this area following
cathodal stimulation at 2.0mA, suggesting an issue more likely
related to electrode polarity than stimulation intensity. While
no significant changes, nor non-significant tendencies toward
changes in any of the metabolites under investigation were
seen during stimulation, even in the five-point analysis, it is
unlikely that allowing a full 20min of stimulation would induce
a measureable effect, though it cannot be ruled out conclusively.
One of the unique features of this study was the use of
continuous, online MRS as opposed to separate acquisitions.
While Hone-Blanchet et al. (23) also acquired spectra during
stimulation, also using a MEGA-PRESS sequence with an echo
time of 68ms and 11min acquisition blocks, their study does
not include a pre-stimulation window. Similarly, Clark et al. (22)
acquired multiple spectra during the pre- and post-stimulation
windows, also using a MEGA-PRESS sequence with an echo
time of 68ms, but with spectra acquired sequentially rather than
continuously in blocks of 4min and 48 s. While there is little
difference in terms of the resultant spectra whether acquired
continuously or sequentially, acquiring separate scans may
introduce more variability as each pre-scan affects parameters
such as shim, gain adjustment and center-frequency tuning
between each segment. It may be considered more robust to
acquire all spectra with the same parameters, as was done in
this study with single continuous acquisitions. Compared with
previous studies using similar sequences, comparable or shorter
acquisition times, and smaller voxel sizes, i.e., 20 × 20 × 20
mm3 (21, 22, 24), there is little evidence to suggest an error in
the MRS acquisition. Intuitively, a larger voxel size provides a
higher signal-to-noise ratio, but may come at the expense of some
focality in terms of covering the site of stimulation. It is possible
that the larger voxel size used in this studymay have incorporated
spectra from cells not affected by stimulation. However, the voxel
dimensions are still small compared to the surface area of the
stimulating electrode, and tDCS is not a particularly focused
stimulation technique.
The most significant difference between this study and other
studies that have measured biochemical changes associated with
tDCS with MRS is the cortical region being investigated, both
as a stimulation site and volume of interest in spectroscopy.
As Woods et al. (14) illustrated, it cannot be taken for granted
that all cortical areas will respond to stimulation in the same
manner, and compared to areas such as the sensorimotor cortex
and frontal areas such as the dorsolateral prefrontal cortex,
the temporoparietal and temporal regions have not been quite
as thoroughly investigated. One study investigating the use
of anodal tDCS in an adjacent cortical area, namely the left
mid-posterior temporal gyrus, on improving performance in
a range or reading and naming tasks (40) did not find any
significant improvement in performance. Although different
stimulation parameters were used, the agreement between the
null-findings of this and the present study suggest it is possible
that the pSTG and adjacent areas in the region, are not as
responsive to anodal stimulation as other areas that have been
investigated, but that the effectiveness of tDCS as a treatment
for hallucinations is based on its ability to modulate over-active
areas in the brain with cathodal stimulation. That is to say,
anodal stimulation may not affect excitability in the pSTG, but
cathodal stimulation may be effective in modulating activity in
over-active or pathologically active networks such as those that
might be associated with hallucinations. Computer modeling
may be able to determine whether the responsiveness of this
cortical area may be due to anatomical features such as skull
thickness or cerebrospinal fluid density. It may be of interest
to repeat a similar experiment looking at the effects of cathodal
stimulation in this area in conjunction with computer models
that may be able to determine whether the absence of an observed
affect may be attributed to issues of anatomy and current
flow.
In an investigation into the effect of active, intrascanner tDCS
on the BOLD response as measured with functional MRI, Antal
et al. (41) found that the presence of an electric current in the
magnetic field inside an MRI scanner produces artifacts that may
result in confounding false-positive activity patterns. While mild
artifacts were observed during the ramping periods before and
after stimulation, and these spectral frames were removed from
subsequent analyses, there were no artifacts observed during
active or sham stimulation periods. Furthermore, there were no
statistically significant differences observed between the pre- and
post-stimulation windows, where no ongoing active or sham
stimulation was present. This, coupled with the findings of
previous studies using online MRS acquired during stimulation
(23, 24) suggest that interfence caused by ongoing intrascanner
tDCS during spectral acquisition is not a likely source of
error.
Another potential explanation for the null findings of
this experiment is insufficient power as a result of too few
participants. An analysis conducted in G∗Power (42) determined
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there were enough participants to detect at least a medium sized
effect (i.e., effect size > 0.6, 1-β = 0.8, α = 0.05). Many of the
studies that have previously investigated biochemical effects of
tDCS have noted significant findings with smaller sample sizes
than the 19 used in this study, including N = 12 (22), N = 17
(23), and N = 11 (21). To this end it is believed that the study
was sufficiently powered, in terms of the participant sample
size, to detect a comparable effect. One of the problems with
statistical power as outlined by Button et al. (43) is that while
problems of low statistical power are typically associated with
reduced chances of detecting a true effect, they may also reduce
the likelihood of a statistically significant result being indicative
of a true effect. That is, finding false positive effects due to inflated
effect sizes. As Westwood et al. (40) illustrate, while it may be
of value to include more participants in future studies, it calls
the effectiveness of a single session of tDCS into question if the
effects are so small. Referring to a meta-analysis in preparation,
Westwood et al. (40) discuss an analysis of pooled studies looking
at anodal stimulation in the frontal and temporal lobes which
produced a sample size of almost 200 participants in which there
was still no evidence of an effect of a single session of tDCS. In
light of this, it is not believed that an increased sample size would
have improved the outcome of this experiment.
One problem affecting the spectroscopy aspect of this study
is that of how to quantify metabolite levels. Typical methods
make use of water as an endogenous reference, or report the
concentration as a ratio relative to an internal reference such
as creatine or NAA. While creatine is typically favored as an
internal reference (44) its use is complicated when using the
MEGA-PRESS sequence as creatine signals are eliminated during
subtraction and are not present in the difference edited spectrum,
though they may be recovered from the spectra acquired without
an editing pulse (commonly referred to as the “OFF” spectrum in
the spectral pairs used to create the difference spectrum). NAA
was not used as an internal reference as it has been demonstrated
to be affected by anodal tDCS (22, 23), although no changes in
NAA levels were measured over the course of the acquisition. The
use of water as an endogenous reference can be problematic for
studies such as this that attempt to measure metabolic changes in
a dynamic manner, i.e., in relation to activity over time, as MRS
signals have been shown to be susceptible to line-broadening
artifacts associated with local BOLD effects (36). Using a fixed
water reference taken at the end of the acquisition, as was done in
this study, the reference signal was not subject to fluctuations as
the result of a BOLD effect throughout the scan as themetabolites
of interest were, i.e., comparing an unchanging reference to a
signal subject to interferencemay increase the likelihood of a false
change being detected. As a single, fixed water reference was used,
it is difficult to decisively rule out any incidental BOLD-related
fluctuations. However, such fluctuations would likely be manifest
across all metabolites in the FWHM estimate given by LCModel,
which is not seen in our data (Tables 2, 3), making it unlikely to
be a significant source of error. Ideally, an experiment such as this
would benefit from the use of external referencing, such as the
Electronic Reference To access in vivo Concentrations (ERETIC)
method (45, 46).
In interpreting these findings, it is important to consider that
tDCS is regarded as a neuromodulatory technique, it does not
induce activity or action potentials, but rather facilitates increases
or decreases in neuronal excitability. Bikson and Rahman
(47) discuss the idea of activity-selectivity and task-specific
modulation, that is, that tDCS will preferentially modulate a
neuronal network that is already active, while not modulating a
separate network that is inactive. One of the problems with the
region of interest in this study is that it contains the primary
auditory cortex and adjacent areas responsible for the sensation
of sound and processing of speech (48). While other paradigms
have investigated cortical areas that may be associated with a task,
e.g., the primarymotor cortex and force adaptation task (20), that
may distinguish between blocks of activity and rest, the auditory
cortex will experience ongoing sensory input during scanning. It
is possible that no biochemical changes were observed between
blocks as the local cortical circuit was already in an active state
during the pre-stimulation window and that tDCS was not able
to drive a higher level of activity.
In conclusion, using continuous online MRS, no significant
change in the levels of Glx, GABA, or NAA in the left pSTG was
observed that could be attributed to an effect of active, anodal
tDCS. Despite this, the method provides a useful insight into the
acute effects of stimulation paradigms and their effect on local
neuronal circuitry. Further research investigating an effect of
tDCS in this area suggests performing a similar experiment using
cathodal tDCS, redesigning the experiment to allow 20min of
stimulation, perhaps combining this experiment with computer
models and also using an external referencing method to avoid
possible confounding variables associated with how metabolite
levels are measured.
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